Alzheimer’S Disease Drug Market Forecasted to Reach USD 20.3 Billion By 2032, at an Impressive 9.16% CAGR
Market Drivers Fueling Expansion The most prominent driver of the Alzheimer’s Disease Drug Market is the global increase in the aging population. As age is the greatest risk factor for Alzheimer’s disease, the surge in elderly demographics, especially in North America, Europe, and parts of Asia-Pacific, is intensifying demand for preventive and therapeutic solutions. In … Read more